Company news
Enorama Pharma Ab (OMXSTO:ERMA) news
Enorama Pharma Ab news releases on 6ix. Latest, Jun 16, 2026: ENORAMA PHARMA: BULLETIN FROM THE ANNUAL GENERAL MEETING OF ENORAMA PHARMA AB (PUBL)
Press releases & updates
ENORAMA PHARMA: BULLETIN FROM THE ANNUAL GENERAL MEETING OF ENORAMA PHARMA AB (PUBL)
June 16, 2026
Enorama Pharma Q1 Operating Loss Narrows To SEK 10.9 Mln
May 20, 2026
Enorama Pharma: PRESS RELEASE FROM THE EXTRAORDINARY GENERAL MEETING, AND FIRST CONTROL MEETING, IN ENORAMA PHARMA AB (PUBL)
April 7, 2026
Enorama Pharma Reports Q4 Net Sales Of SEK 1.75 Million
March 18, 2026
Balance Sheet For Liquidation Purposes Shows Enorama Pharma Equity Is Less Than Half Of Registered Share Capital
March 11, 2026
Enorama Pharma Postpones Publication Of 2025 Report Due To Control Balance Sheet
March 10, 2026
Enorama Pharma AB (publ) resolves to postpone the planned extraordinary general meeting
March 3, 2026
Enorama Pharma Enters Loan Agreement With DS Global
February 18, 2026
Enorama Pharma Postpones Its 2025 Year-End Report
February 13, 2026
Enorama Pharma Subsidiary Intends To Appeal FDA's Refuse-To-File Decision
February 3, 2026
BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN ENORAMA PHARMA AB (PUBL)
December 2, 2025
Enorama Pharma Q3 Operating Loss Widens To SEK 12.3 Mln
November 19, 2025
Enorama Pharma CEO Daniel Schröder Resigns
November 4, 2025
ERMA: Sharp revenue decline and deepening losses in H1 2025 amid US transition and PMTA focus
August 20, 2025
ERMA: Losses deepened as Enorama Pharma restructures for US white snus growth and seeks new funding
May 21, 2025
ERMA: Strong US snus growth offset by NRT write-down; urgent capital needs remain
February 19, 2025
ERMA: Net sales rose sharply and losses narrowed as US pouch sales accelerated
November 20, 2024
ERMA: US pouch sales drove revenue growth and improved liquidity, with narrowed losses
August 21, 2024